Dong Z Z, Zhu X D, Li Z, Mao Y G, Chai Y L, Yao D F, Sun H C, Zhu J Y, Ma K S
Affiliated Hospital of Nantong University, Nantong Jiangsu Province 226001, China.
Department of Liver Surgery, Liver Cancer Institute, Zhongshan Hospital, Fudan University, Shanghai 200032, China.
Zhonghua Gan Zang Bing Za Zhi. 2017 Feb 20;25(2):85-93. doi: 10.3760/cma.j.issn.1007-3418.2017.02.002.
Hepatocellular carcinoma (HCC) is still one of common malignant cancers worldwide, with increasing incidence and mortality rates. Early diagnosis and effective treatment for HCC remain to be explored. This article introduces the research advances in the early specific diagnosis and effective therapies for HCC in 2016, such as molecular markers in the specific diagnosis and targeted therapy for HCC, main therapeutic regimens, robot-assisted liver resection, and no-touch radiofrequency ablation.
肝细胞癌（HCC）仍然是全球常见的恶性肿瘤之一，其发病率和死亡率呈上升趋势。HCC的早期诊断和有效治疗仍有待探索。本文介绍了2016年HCC早期特异性诊断和有效治疗的研究进展，如HCC特异性诊断中的分子标志物和靶向治疗、主要治疗方案、机器人辅助肝切除术以及非接触式射频消融。
